Ocumension Therapeutics (1477.HK) HKSE
7.50
-0.1(-1.32%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.50
-0.1(-1.32%)
Currency In HKD
| Market Cap | 5.28B |
| Enterprise Value | 5.06B |
| P/E Ratio | -33.83 |
| PEG Ratio | -0.56 |
| Price/Sales Ratio | 6.61 |
| Price/Book Ratio | 1.45 |
| Enterprise/Revenue | 6.34 |
| Enterprise/EBITDA | -53.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.2 |
| Operating Margin | -0.2 |
| Return On Assets | -0.04 |
| Return On Equity | -0.04 |
| Revenue | 783.53M |
| Revenue/Share | 0.97 |
| Gross Profit | 343.08M |
| EBITDA | -147.56M |
| Net Income | -154.71M |
| Diluted EPS | -0.2 |
| Total Cash | 402.63M |
| Total Cash/Share | 0.49 |
| Total Debt | 187.62M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 3.7 |
| Book Value Per Share | 4.49 |
| 52-Week Change | 35.62 |
| 52-Week High | 12.23 |
| 52-Week Low | 5.01 |
| Moving Average 50 Days | 7.42 |
| Moving Average 200 Days | 8.32 |
| Average Volume | 920,522 |
| Shares Outstanding | 804.81M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |